Michael Chary MD, PhD

Happy Monday! The latest episode of Tox in Ten ACMT Highlights is live! @gillianbchum sits down with @macacharya to discuss the role of artificial intelligence in medical toxicology @acmtmedtox podcasts.apple.com/us/podcast/tox…

The best way to spend your Monday is listening to the newest @ToxInTen episode! @gillianbchum sits down with @macacharya to discuss the role of artificial intelligence in medical toxicology. #ToxTwitter #MedTwitter

Dear friends of @eapcct This week #toxreadingcorner is on “The Role and Promise of Artificial Intelligence in Medical Toxicology” by Michael A. Chary et al. link.springer.com/article/10.100… @macacharya @ManiniAlex @PEMTox

Toxicology 2.0 symposium, now speaking: The geospatial and linguistic dynamics of conversations on Twitter about vaping. Michael Chary (2020 -Abstract 099) #EAPCCT2021 @macacharya

.@macacharya @ToxInNewEngland: ‘A #transparentAI system may be useful by automating aspects [of] routine cases and in doing so freeing up expert time for more complicated cases’ of #overdose or #poisoning. #Toxicology #ExplainableAI ow.ly/413M50EVaZL

@eapcct Also related, our paper using probabilistic logical networks to diagnose toxidromes: urldefense.proofpoint.com/v2/url?u=https… Sounds like a collab opportunity

Looking forward to attend the YIA session of the #EAPCCT2021 to hear an update on this topic: Tobias Zellner will present data on “Decision support for toxin prediction using artificial intelligence” (Thursday 27th-1pmCET)

Listening to my colleague Michael Chary MD PhD discuss AI in medical toxicology. #2021ACMT @acmtmedtox @WCMEmergency

#2021ACMT Happening now: @macacharya shines a light on the role artificial intelligence can play in medical toxicology during his 2:30 PM talk. @WeillCornell

@ManiniAlex @NYEmergency And, link to the ontology repository: github.com/mac389/toxicol…

Successful use of ECMO and lipid emulsion for massive bupropion overdose: a case report doi.org/10.1080/247343… from @MikeEMPharmD @macacharya @philmoonsamy et al @MassGeneralNews Well documented #bupropion poisoning treated with #ECMO and ILE.

Exposure To Other Coronaviruses Does Not Give Immunity Against SARS-CoV-2 brief19.com/2021/02/12/bri… via @Brief_19 @macacharya

Here's the @Brief_19 Week in Review for COVID-19 research! Take three minutes and catch up on the must know stories from the frontline this week. Expertise from @angie_rasmussen @JPBelinkieMD @macacharya brief19.com/2021/02/13/bri… via @Brief_19

@jeremyfaust @Brief_19 Information is everywhere. But, wisdom?

Managing The Second Pandemic—Information Overload! brief19.com/2021/02/08/bri…

Check out my analysis on the new #modernavaccine trial. #CovidVaccine #COVID19

Our latest paper in Toxicology Communications: Early intravenous lipid emulsion therapy for diphenhydramine overdose: a case report. tandfonline.com/doi/full/10.10…

Back in June, @macacharya wrote a brief on a small trial of colchicine in Covid-19 for @Brief_19. The results were promising. New findings publicized via press release (COLCORONA trial) are far too vague to be useful. But here's what we do know... 👇 brief19.com/2020/06/25/bri…

Daily briefings from @Brief_19 return tomorrow AM! This week: frontline expertise on the latest in Covid-19 medical research from @bernardchangMD @sampx @macacharya and @JPBelinkieMD. Written by docs *for everyone* Subscribe free and get it first! 🙌 brief19.com/subscribe/

BinaxNOW Antigen Testing Can Be Used In Asymptomatic Individuals. Is It Ready For Prime Time? First, we must ask the right question... brief19.com/2021/01/21/bri… via @Brief_19 @macacharya

Abbott's new rapid antigen test, BinaxNOW, has received EUA from the @US_FDA. @macacharya on a new @CDCgov study evaluating use in asymptomatic individuals & what this means: #binaxnow-antigen-testing-can-be-used-in-asymptomatic-individuals-is-it-ready-for-prime-time" target="_blank" rel="nofollow noopener">brief19.com/2021/01/21/bri…

Check out my summary of the #Covid_19 @moderna_tx #vaccine ! @NEJM